FrancophonIA/ELRC3.0 huggingface dataset:
English: 1 tablet contains 20 mg of mavacoxib.
Croatian: 1 tableta sadrži 20 mg mavakoksiba.
English: WITHDRAWAL PERIOD(S) Not applicable
Croatian: KARENCIJA(E) Nije primjenjivo.
English: 1 tablet contains 75 mg of mavacoxib.
Croatian: 1 tableta sadrži 75 mg mavakoksiba.
English: BATCH NUMBER
Croatian: Kartonska kutija
English: Carton
Croatian: Sukroza
English: What Xelevia is and what it is used for
Croatian: Što je Xelevia i za što se koristi
English: POLPHARMA Biuro Handlowe Sp. z o.o.
Croatian: POLPHARMA Biuro Handlowe Sp. z o.o. Tel.
English: STOP taking Xelevia and contact a doctor immediately if you notice any of the following serious side effects:
Croatian: PRESTANITE uzimati lijek Xelevia i odmah se javite liječniku ako primijetite bilo koju od sljedećih ozbiljnih nuspojava:
English: Do not take Xelevia - if you are allergic to sitagliptin or any of the other ingredients of this medicine (listed in section 6).
Croatian: Nemojte uzimati lijek Xelevia - ako ste alergični na sitagliptin ili neki drugi sastojak ovog lijeka (naveden u dijelu 6).
English: What Xelevia looks like and contents of the pack
Croatian: Kako Xelevia izgleda i sadržaj pakiranja
English: Other medicines and Xelevia
Croatian: Drugi lijekovi i Xelevia
English: What Xelevia contains
Croatian: Što Xelevia sadrži
English: Your doctor may ask you to stop Xelevia.
Croatian: Vaš liječnik može zatražiti da prestanete s uzimanjem lijeka Xelevia.
English: Due to lack of human data, Xelevia should not be used during pregnancy.
Croatian: Zbog nedostatka podataka o primjeni u ljudi, Xelevia se ne smije uzimati tijekom trudnoće.
English: If you take more Xelevia than you should If you take more than the prescribed dosage of this medicine, contact your doctor immediately.
Croatian: Ako uzmete više lijeka Xelevia nego što ste trebali Uzmete li veću dozu ovog lijeka od propisane, odmah se javite svom liječniku.
English: - an allergic reaction to Xelevia (see section 4).
Croatian: - Alergijsku reakciju na lijek Xelevia (pogledajte dio 4).
English: What Xelevia is and what it is used for What you need to know before you take Xelevia How to take Xelevia
Croatian: Što je Xelevia i za što se koristi Što morate znati prije nego počnete uzimati lijek Xelevia Kako uzimati lijek Xelevia
English: Date of first authorisation: 21 March 2007 Date of latest renewal: 20 January 2012
Croatian: Datum posljednje obnove odobenja: 20. siječnja 2012.
English: The level of digoxin in your blood may need to be checked if taking with Xelevia.
Croatian: Možda će biti potrebno provjeravati razinu digoksina u Vašoj krvi ukoliko se uzima s lijekom Xelevia.
English: Method of administration Xelevia can be taken with or without food.
Croatian: Način primjene Xelevia se može uzimati s hranom ili bez nje.
English: What you need to know before you take Xelevia
Croatian: Što morate znati prije nego počnete uzimati lijek Xelevia
English: Xelevia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.
Croatian: Xelevia se ne smije primjenjivati u bolesnika s dijabetesom tipa 1 ili za liječenje dijabetičke ketoacidoze.
English: For adult patients with type 2 diabetes mellitus, Xelevia is indicated to improve glycaemic control:
Croatian: U odraslih bolesnika s dijabetesom mellitus tipa 2, Xelevia je indicirana za poboljšanje regulacije glikemije:
English: The European Medicines Agency has deferred the obligation to submit the results of studies with Xelevia in one or more subsets of the paediatric population in type 2 diabetes mellitus (see section 4.2 for information on paediatric use).
Croatian: Europska agencija za lijekove odgodila je obvezu podnošenja rezultata ispitivanja lijeka Xelevia u jednoj ili više podskupina pedijatrijske populacije za dijabetes mellitus tipa 2 (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: These medical conditions can increase your chance of getting pancreatitis (see section 4).
Croatian: Ove zdravstvene tegobe mogu povećati vjerojatnost da dobijete pankreatitis (pogledajte dio 4).
English: If pancreatitis is suspected, Xelevia and other potentially suspect medicinal products should be discontinued; if acute pancreatitis is confirmed, Xelevia should not be restarted.
Croatian: Posumnja li se na pankreatitis, mora se prekinuti primjena lijeka Xelevia i drugih lijekova za koje se sumnja da bi ga mogli izazvati; potvrdi li se akutni pankreatitis, liječenje lijekom Xelevia ne smije se ponovno započeti.
English: Since co-administration of a high-fat meal with sitagliptin had no effect on the pharmacokinetics, Xelevia may be administered with or without food.
Croatian: Budući da istodobno uzimanje sitagliptina s punomasnim obrokom nema učinka na farmakokinetiku, Xelevia se može uzimati s hranom ili bez nje.
English: Rates of Composite Cardiovascular Outcomes and Key Secondary Outcomes sitagliptin 100 mg
Croatian: Tablica 3. Stope objedinjenih kardiovaskularnih ishoda i ključnih sekundarnih ishoda sitagliptin 100 mg
English: Xelevia is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
Croatian: Xelevia je također indicirana kao dodatak inzulinu (sa ili bez metformina) kada dijeta i tjelovježba uz stabilnu dozu inzulina ne omogućuju odgovarajuću regulaciju glikemije.
English: Xelevia has not been studied in patients with severe hepatic impairment and care should be exercised (see section 5.2).
Croatian: Xelevia nije ispitivana u bolesnika s teškim oštećenjem funkcije jetre, te je potreban oprez (vidjeti dio 5.2).
English: Because there is a dosage adjustment based upon renal function, assessment of renal function is recommended prior to initiation of Xelevia and periodically thereafter.
Croatian: S obzirom da se doza prilagođava temeljem bubrežne funkcije, preporučuje se procijeniti bubrežnu funkciju prije uvođenja lijeka Xelevia te periodično nakon toga.
English: Hypoglycaemia when used in combination with other anti-hyperglycaemic medicinal products In clinical trials of Xelevia as monotherapy and as part of combination therapy with medicinal products not known to cause hypoglycaemia (i.e. metformin and/or a PPAR agonist), rates of hypoglycaemia reported with sitagliptin were similar to rates in patients taking placebo.
Croatian: Hipoglikemija pri uzimanju u kombinaciji s drugim antihiperglikemijskim lijekovima U kliničkim ispitivanjima lijeka Xelevia kao monoterapije ili kao dio kombinirane terapije s lijekovima za koje nije poznato da uzrokuju hipoglikemiju (tj. metforminom i/ili agonistom PPAR), stope prijavljenih hipoglikemija u bolesnika koji su uzimali sitagliptin bile su podjednake onoj u bolesnika koji su uzimali placebo.
English: If you stop taking Xelevia
Croatian: Ako prestanete uzimati lijek Xelevia
English: When Xelevia is used in combination with a sulphonylurea or with insulin, a lower dose of the sulphonylurea or insulin may be considered to reduce the risk of hypoglycaemia (see section 4.4).
Croatian: Kada se Xelevia uzima u kombinaciji sa sulfonilurejom ili inzulinom, može se razmotriti niža doza sulfonilureje ili inzulina kako bi se smanjio rizik od hipoglikemije (vidjeti dio 4.4).
English: If you forget to take Xelevia
Croatian: Ako ste zaboravili uzeti lijek Xelevia
English: When used in combination with metformin and/or a PPAR agonist, the dose of metformin and/or PPAR agonist should be maintained, and Xelevia administered concomitantly.
Croatian: Kada se uzima u kombinaciji s metforminom i/ili agonistom PPAR, mora se zadržati ista doza metformina i/ili agonista PPAR, uz istodobnu primjenu lijeka Xelevia.
English: In addition, patients should be alerted to the risk of hypoglycaemia when Xelevia is used in combination with a sulphonylurea or with insulin.
Croatian: Bolesnike se također mora upozoriti na rizik od hipoglikemije kad se Xelevia uzima u kombinaciji sa sulfonilurejom ili s inzulinom.
English: No dose adjustment for Xelevia is necessary for patients with mild or moderate hepatic impairment (Child-Pugh score  9).
Croatian: Nije potrebna prilagodba doze lijeka Xelevia u bolesnika s blagim ili umjerenim oštećenjem funkcije jetre (Child-Pugh rezultat ≤ 9).
English: Xelevia contains the active substance sitagliptin which is a member of a class of medicines called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus.
Croatian: Xelevia sadrži djelatnu tvar sitagliptin, koja pripada skupini lijekova koji se zovu DPP-4 inhibitori (inhibitori dipeptidil-peptidaze 4), koji snižavaju razine šećera u krvi u odraslih bolesnika sa šećernom bolešću tipa 2.
English: Xelevia should not be used during breast-feeding.
Croatian: Xelevia se ne smije uzimati tijekom dojenja.
English: If a dose of Xelevia is missed, it should be taken as soon as the patient remembers.
Croatian: Propusti li bolesnik dozu lijeka Xelevia, treba je uzeti čim se sjeti.
English: If a hypersensitivity reaction is suspected, Xelevia should be discontinued.
Croatian: Pri sumnji na reakciju preosjetljivosti mora se prekinuti uzimanje lijeka Xelevia.
English: Xelevia is a member of a class of oral anti-hyperglycaemic agents called dipeptidyl peptidase 4 (DPP-4) inhibitors.
Croatian: Xelevia pripada skupini oralnih antihiperglikemijskih lijekova koji se zovu inhibitori dipeptidil-peptidaze 4 (DPP-4).
English: Paediatric No studies with Xelevia have been performed in paediatric patients.
Croatian: Pedijatrijska populacija Nisu provedena ispitivanja lijeka Xelevia u pedijatrijskih bolesnika.
English: Xelevia has no or negligible influence on the ability to drive and use machines.
Croatian: Xelevia ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: Cases of inflammation of the pancreas (pancreatitis) have been reported in patients receiving Xelevia (see section 4).
Croatian: U bolesnika koji su uzimali lijek Xelevia prijavljeni su slučajevi upale gušterače (pankreatitis) (pogledajte dio 4.).
English: How to store Xelevia
Croatian: Kako čuvati lijek Xelevia
English: How to take Xelevia
Croatian: Kako uzimati lijek Xelevia
English: For patients with severe renal impairment (GFR ≥ 15 to <30 mL/min) or with end-stage renal disease (ESRD) (GFR < 15 mL/min), including those requiring haemodialysis or peritoneal dialysis, the dose of Xelevia is 25 mg once daily.
Croatian: U bolesnika s teškim oštećenjem funkcije bubrega (GFR ≥ 15 do < 30 ml/min) ili onih u završnoj fazi bubrežne bolesti, (engl. end stage renal disease, ESRD) (GFR < 15 ml/min), uključujući i one kojima je potrebna hemodijaliza ili peritonealna dijaliza, doza lijeka Xelevia je 25 mg jedanput na dan.
English: For patients with moderate renal impairment (GFR  30 to < 45 mL/min), the dose of Xelevia is 50 mg once daily.
Croatian: U bolesnika s umjerenim oštećenjem funkcije bubrega (GFR ≥ 30 do < 45 ml/min) doza lijeka Xelevia je 50 mg jedanput na dan.
English: Neopharmed Gentili S.p.A. Tel: +39 02891321 regulatory@neogen.it
Croatian: Tel: +39 02891321 regulatory@neogen.it
English: If bullous pemphigoid is suspected, Xelevia should be discontinued.
Croatian: Pri sumnji na bulozni pemfigoid treba prekinuti liječenje lijekom Xelevia.
English: Xelevia 25 mg tablets Sitagliptin
Croatian: Xelevia 25 mg tablete sitagliptin
English: Xelevia 100 mg tablets Sitagliptin
Croatian: Xelevia 100 mg tablete sitagliptin
English: It is important to stay on the diet and exercise recommended by your doctor while taking Xelevia.
Croatian: Dok uzimate lijek Xelevia, važno je da se pridržavate preporuka svog liječnika o dijeti i tjelovježbi.
English: Compared to normal healthy control subjects, plasma AUC of sitagliptin was increased by approximately 1.2-fold and 1.6-fold in patients with mild renal impairment (GFR ≥ 60 to
Croatian: U usporedbi sa zdravim kontrolnim ispitanicima, u bolesnika s blagim oštećenjem funkcije bubrega (GFR od ≥ 60 do < 90 ml/min) i bolesnika s umjerenim oštećenjem funkcije bubrega (GFR ≥ 45 do < 60 ml/min) AUC sitagliptina u plazmi je bio povišen 1,2 puta odnosno 1,6 puta.
English: Xelevia 50 mg tablets Sitagliptin
Croatian: Xelevia 50 mg tablete sitagliptin
English: EU/1/07/382/013 EU/1/07/382/014 EU/1/07/382/015 EU/1/07/382/016 EU/1/07/382/017 EU/1/07/382/018 EU/1/07/382/023 EU/1/07/382/024
Croatian: EU/1/07/382/015 EU/1/07/382/016 EU/1/07/382/017 EU/1/07/382/018 EU/1/07/382/023 EU/1/07/382/024
English: EU/1/07/382/001 EU/1/07/382/002 EU/1/07/382/003 EU/1/07/382/004 EU/1/07/382/005 EU/1/07/382/006 EU/1/07/382/019 EU/1/07/382/020
Croatian: EU/1/07/382/003 EU/1/07/382/004 EU/1/07/382/005 EU/1/07/382/006 EU/1/07/382/019 EU/1/07/382/020
English: EU/1/07/382/007 EU/1/07/382/008 EU/1/07/382/009 EU/1/07/382/010 EU/1/07/382/011 EU/1/07/382/012 EU/1/07/382/021 EU/1/07/382/022
Croatian: EU/1/07/382/009 EU/1/07/382/010 EU/1/07/382/011 EU/1/07/382/012 EU/1/07/382/021 EU/1/07/382/022
English: Round, light beige film-coated tablet with “112”on one side.
Croatian: Okrugla, svijetlobež, filmom obložena tableta s oznakom "112" na jednoj strani.
English: Round, light beige film-coated tablet with “112” on one side.
Croatian: Okrugla, svjetlobež, filmom obložena tableta s oznakom "112" na jednoj strani.
English: EU/1/07/382/013 14 film-coated tablets EU/1/07/382/014 28 film-coated tablets EU/1/07/382/023 30 film-coated tablets EU/1/07/382/015 56 film-coated tablets EU/1/07/382/016 84 film-coated tablets EU/1/07/382/024 90 film-coated tablets EU/1/07/382/017 98 film-coated tablets EU/1/07/382/018 50 x 1 film-coated tablets
Croatian: EU/1/07/382/013 14 filmom obloženih tableta EU/1/07/382/014 28 filmom obloženih tableta EU/1/07/382/023 30 filmom obloženih tableta EU/1/07/382/015 56 filmom obloženih tableta EU/1/07/382/016 84 filmom obloženih tableta EU/1/07/382/024 90 filmom obloženih tableta EU/1/07/382/017 98 filmom obloženih tableta EU/1/07/382/018 50 x 1 filmom obložena tableta
English: EU/1/07/382/007 14 film-coated tablets EU/1/07/382/008 28 film-coated tablets EU/1/07/382/021 30 film-coated tablets EU/1/07/382/009 56 film-coated tablets EU/1/07/382/010 84 film-coated tablets EU/1/07/382/022 90 film-coated tablets EU/1/07/382/011 98 film-coated tablets EU/1/07/382/012 50 x 1 film-coated tablets
Croatian: EU/1/07/382/007 14 filmom obloženih tableta EU/1/07/382/008 28 filmom obloženih tableta EU/1/07/382/021 30 filmom obloženih tableta EU/1/07/382/009 56 filmom obloženih tableta EU/1/07/382/010 84 filmom obloženih tableta EU/1/07/382/022 90 filmom obloženih tableta EU/1/07/382/011 98 filmom obloženih tableta EU/1/07/382/012 50 x 1 filmom obložena tableta
English: EU/1/07/382/001 14 film-coated tablets EU/1/07/382/002 28 film-coated tablets EU/1/07/382/019 30 film-coated tablets EU/1/07/382/003 56 film-coated tablets EU/1/07/382/004 84 film-coated tablets EU/1/07/382/020 90 film-coated tablets EU/1/07/382/005 98 film-coated tablets EU/1/07/382/006 50 x 1 film-coated tablets
Croatian: EU/1/07/382/001 14 filmom obloženih tableta EU/1/07/382/002 28 filmom obloženih tableta EU/1/07/382/019 30 filmom obloženih tableta EU/1/07/382/003 56 filmom obloženih tableta EU/1/07/382/004 84 filmom obloženih tableta EU/1/07/382/020 90 filmom obloženih tableta EU/1/07/382/005 98 filmom obloženih tableta EU/1/07/382/006 50 x 1 filmom obložena tableta
English: Xelevia 100 mg film-coated tablets Sitagliptin
Croatian: Xelevia 100 mg filmom obložene tablete sitagliptin
English: Xelevia 25 mg film-coated tablets
Croatian: Xelevia 25 mg filmom obložene tablete
English: Xelevia 100 mg film-coated tablets
Croatian: Xelevia 100 mg filmom obložene tablete
English: Xelevia 25 mg film-coated tablets Sitagliptin
Croatian: Xelevia 25 mg filmom obložene tablete sitagliptin
English: Xelevia 50 mg film-coated tablets
Croatian: Xelevia 50 mg filmom obložene tablete
English: Xelevia 50 mg film-coated tablets Sitagliptin
Croatian: Xelevia 50 mg filmom obložene tablete sitagliptin
English: Tel: + 386 1 5204 201 msd_slovenia@merck.com
Croatian: Merck Sharp & Dohme, inovativna zdravila d.o.o. Tel: + 386 1 5204 201 msd_slovenia@merck.com
English: --¹ After reconstitution, one dose (0.5 mL) contains:
Croatian: Nakon rekonstitucije jedna doza (0,5 ml) sadrži:
English: Chimeric yellow fever dengue virus serotype 1* (live, attenuated).............................................4.5 - 6.0 log10 CCID50/dose** Chimeric yellow fever dengue virus serotype 2* (live, attenuated).............................................4.5 - 6.0 log10 CCID50/dose** Chimeric yellow fever dengue virus serotype 3* (live, attenuated).............................................4.5 - 6.0 log10 CCID50/dose** Chimeric yellow fever dengue virus serotype 4* (live, attenuated).............................................4.5 - 6.0 log10 CCID50/dose** * Produced in Vero cells by recombinant DNA technology.
Croatian: Kimerički virus žute groznice/denge serotipa 1 (živi, atenuirani)* ... 4,5 - 6,0 log10 CCID50 po dozi** Kimerički virus žute groznice/denge serotipa 2 (živi, atenuirani)* ... 4,5 - 6,0 log10 CCID50 po dozi** Kimerički virus žute groznice/denge serotipa 3 (živi, atenuirani)* ... 4,5 - 6,0 log10 CCID50 po dozi** Kimerički virus žute groznice/denge serotipa 4 (živi, atenuirani)* ...
English: ** CCID50: 50% Cell Culture Infectious Dose.
Croatian: **CCID50: količina virusa kojom se zarazi 50% stanične kulture.
English: 5 sets of 2 vials (1 with powder + 1 with solvent, 5 doses each)
Croatian: 5 setova od 2 bočice (1 sa praškom + 1 sa otapalom, svaka sa 5 doza)
English: 10 vials + 10 pre-filled syringes
Croatian: 10 bočica + 10 napunjenih štrcaljki
English: 10 vials + 10 pre-filled syringes + 20 needles
Croatian: 10 bočica + 10 napunjenih štrcaljki + 20 igala štrcaljka
English: 1 vial + 1 pre-filled syringe + 2 needles
Croatian: Veličina pakiranja štrcaljka + 2 igle
English: Powder: 5 doses; solvent: 2.5 ml
Croatian: 4,5 - 6,0 log10 CCID50 po dozi**
English: This may take up to 20 minutes.
Croatian: Ovo može potrajati do 20 minuta.
English: These events may also be more severe.
Croatian: Ovi događaji mogu biti i teži.
English: This is to be expected and is not a cause for concern.
Croatian: To se može očekivati i nije razlog za zabrinutost.
English: Some patients have actually committed suicide.
Croatian: Neki bolesnici su stvarno počinili samoubojstvo.
English: 48 weeks
Croatian: 48 tjedna
English: Before reconstitution 3 years.
Croatian: Prije rekonstitucije 3 godine.
English: • Look in the window.
Croatian: • Pogledajte kroz prozorčić.
English: - The contents should now be completely dissolved.
Croatian: - Sadržaj bi sada trebao biti potpuno otopljen.
English: Some bubbles may be present, but this is normal.
Croatian: U njoj može biti nekoliko mjehurića, ali to je normalno.
English: Wait for the area to dry.
Croatian: Pričekajte da se to područje osuši.
English: The frequency of such re-activation appears to be low.
Croatian: Čini se da je učestalost takve reaktivacije niska.
English: • Find a well-lit, clean flat work surface such as a table.
Croatian: • Pronađite dobro osvijetljenu, čistu i ravnu radnu površinu, poput stola.
English: Therefore, your blood will be checked regularly to be sure that the HIV infection is not getting worse.
Croatian: Stoga ćete redovito obavljati krvne pretrage kako bi se uvjerili da se HIV infekcija ne pogoršava.
English: Additional 5 seconds ensures complete dose delivery.
Croatian: Dodatnih 5 sekundi jamči primjenu cijele doze.
English: You will need the following supplies that are included in the package:
Croatian: Trebat će Vam sljedeći pribor, koji je uključen u pakiranje:
English: Injecting it at the same time of day each week will help you not to forget to take it.
Croatian: Davanje injekcije u isto doba dana svakog tjedna pomoći će Vam da ne zaboravite uzeti lijek.
English: Another approximately 2 % had a transient decrease below the lower limit of normal.
Croatian: Dodatnih oko 2% ih je imalo prolazno sniženje ispod donje granice normale.
English: Wash your hands carefully.
Croatian: Dobro operite ruke.
English: • Wash your hands well with soap and warm water.
Croatian: • Temeljito operite ruke sapunom i toplom vodom.
English: Some children did not reach their projected height within 1-5.5 years after completing treatment.
Croatian: Neka djeca nisu dostigla svoju planiranu visinu unutar 1-5,5 godina nakon završetka liječenja.
English: Take/administer the dose of this medicine as soon as you remember, but only if within 1-2 days after the forgotten dose.
Croatian: Uzmite/primijenite dozu ovog lijeka čim se sjetite, ali samo unutar 1-2 dana nakon zaboravljene doze.
English: % (number) of patients
Croatian: % (broj) bolesnika
English: If necessary, the dose may be changed during treatment.
Croatian: Ako bude potrebno, doza se može mijenjati tijekom liječenja.
English: Other side effects that have been reported in adults include:
Croatian: Ostale nuspojave koje su prijavljene u odraslih osoba uključuju:
English: Your doctor will monitor you for signs and symptoms of these conditions.
Croatian: Liječnik će Vas nadzirati zbog znakova i simptoma ovih stanja.
English: Any or all of these activities may contribute to interferon's therapeutic effects.
Croatian: Pojedino ili sva ova djelovanja mogu pridonijeti terapijskim učincima interferona.
English: Number of capsules (200 mg)
Croatian: Broj kapsula (200 mg)
English: Inject this medicine once each week on the same day.
Croatian: Injekciju ovog lijeka primijenite jedanput na tjedan, uvijek u isti dan.
English: Ribavirin can be very damaging to an unborn baby.
Croatian: Ribavirin može izazvati teška oštećenja nerođenog djeteta.
English: Date of first authorisation: 29 May 2000 Date of latest renewal: 29 May 2010
Croatian: Datum posljednje obnove odobrenja: 29. svibnja 2010.
English: The effect of this medicine on human pregnancy is not known.
Croatian: Učinak ovog lijeka na trudnoću u ljudi nije poznat.
English: It is considered that graft rejection reactions may be induced.
Croatian: Smatra se da može doći do poticanja reakcija odbacivanja presatka.
English: Pull the needle straight out of the skin.
Croatian: Izvucite iglu ravno iz kože.
English: If the solution is cold, warm the syringe between your palms.
Croatian: Ako je otopina hladna, zagrijte štrcaljku između dlanova.
English: Administer once weekly (ml)
Croatian: Primijeniti jedanput na tjedan (ml)
English: These events included suicidal ideation and attempted suicide (see section 4.4).
Croatian: Ti su događaji uključivali suicidalne misli i pokušaj suicida (vidjeti dio 4.4).
English: Elderly ( 65 years of age)
Croatian: Starije osobe (≥ 65 godina)
English: The maximum daily dose reported is 1,200 µg for one day.
Croatian: Prijavljena maksimalna dnevna doza je 1200 µg u jednom danu.
English: In studies in pregnant animals, interferons have sometimes caused miscarriage.
Croatian: U istraživanjima na gravidnim životinjama interferoni su ponekad izazvali pobačaj.
English: These studies were limited to four weeks due to the appearance of anti-interferon antibodies in most monkeys.
Croatian: Trajanje tih istraživanja bilo je ograničeno na četiri tjedna zbog pojave anti-interferonskih protutijela u većine majmuna.
English: This causes severe anaemia, symptoms of which would include unusual tiredness and a lack of energy.
Croatian: To uzrokuje tešku anemiju, čiji simptomi mogu biti neuobičajen umor i manjak energije.
English: Therefore, you should not breast-feed an infant if you are taking this medicine.
Croatian: Stoga ne smijete dojiti dijete ako uzimate ovaj lijek.
English: Metabolism of other medicines in the liver may be suppressed.
Croatian: Metabolizam drugih lijekova u jetri možda će biti potisnut.
English: Ribavirin capsules
Croatian: Ribavirin kapsule
English: When this medicine is used alone, some of these effects are less likely to occur, and some have not occurred at all.
Croatian: Kada se ovaj lijek uzima samostalno, za neke od ovih nuspojava manje je vjerojatno da će se pojaviti, a neke se uopće nisu pojavile.
English: Use this solution immediately.
Croatian: Tu otopinu upotrijebite odmah.
English: Therefore, you must not take this medicine at the same time as telbivudine.
Croatian: Stoga ne smijete uzimati ovaj lijek istodobno s telbivudinom.
English: * Must use vial.
Croatian: * Mora se koristiti bočica.
English: Alopecia, dry skin
Croatian: alopecija, suha koža